Literature DB >> 10208725

Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat.

S Borovec1, C Broumis, W Adcock, R Fang, E Uren.   

Abstract

To determine the efficacy of a clean-in-place system for the inactivation of viruses present in human plasma, the effect of 0.1 M sodium hydroxide at 60 degrees C on viral infectivity was investigated. Inactivation of the following model and relevant viruses were followed as a function of time: human hepatitis A virus (HAV), canine parvovirus (CPV; a model for human parvovirus B-19) pseudorabies virus (PRV, a model for hepatitis B virus), and bovine viral diarrhoea virus (BVDV, a model for hepatitis C virus and human immunodeficiency virus). Infectivity of CPV was determined by a novel in situ EIA method which will prove useful for studies to validate parvovirus inactivation or removal. Infectivity of BVDV, PRV and CPV were shown to be reproducibly inactivated below the limit of detection by 0.1 M NaOH at 60 degrees C within 30 s. HAV was inactivated to below the limit of detection within 2 min. Treatment with heat alone also resulted in some log reduction for all viruses tested except for CPV which remained unaffected after heating at 60 degrees C for 16 min. Treatment of HAV with hydroxide alone (up to 1.0 m) at 15 degrees C did not lead to rapid inactivation. Collectively, these data suggest that 0.1 M NaOH at 60 degrees C for two min should be sufficient to inactivate viruses present in process residues. Copyright 1998 The International Association of Biological Standardization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10208725     DOI: 10.1006/biol.1998.0146

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  7 in total

1.  Survival of bacterial indicator species and bacteriophages after thermal treatment of sludge and sewage.

Authors:  Laura Mocé-Llivina; Maite Muniesa; Hugo Pimenta-Vale; Francisco Lucena; Juan Jofre
Journal:  Appl Environ Microbiol       Date:  2003-03       Impact factor: 4.792

2.  The use of phenothiazine dyes to inactivate bovine viral diarrhea virus in goat colostrum.

Authors:  Kevin E Washburn; Robert N Streeter; Jeremiah T Saliki; Terry W Lehenbauer
Journal:  Can J Vet Res       Date:  2004-04       Impact factor: 1.310

3.  Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2.

Authors:  Eric Gaudreault; Stéphanie Fiola; Martin Olivier; Jean Gosselin
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

4.  The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics.

Authors:  Elisabeth Casademunt; Kristina Martinelle; Mats Jernberg; Stefan Winge; Maya Tiemeyer; Lothar Biesert; Sigurd Knaub; Olaf Walter; Carola Schröder
Journal:  Eur J Haematol       Date:  2012-06-15       Impact factor: 2.997

5.  Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma.

Authors:  Caroline Goussen; Steve Simoneau; Soline Bérend; Christine Jehan-Kimmel; Anne Bellon; Céline Ducloux; Bruno You; Philippe Paolantonacci; Monique Ollivier; Ludovic Burlot; Sami Chtourou; Benoît Flan
Journal:  BioDrugs       Date:  2017-06       Impact factor: 5.807

6.  A Universal Next-Generation Sequencing Protocol To Generate Noninfectious Barcoded cDNA Libraries from High-Containment RNA Viruses.

Authors:  Lindsey A Moser; Lisbeth Ramirez-Carvajal; Vinita Puri; Steven J Pauszek; Krystal Matthews; Kari A Dilley; Clancy Mullan; Jennifer McGraw; Michael Khayat; Karen Beeri; Anthony Yee; Vivien Dugan; Mark T Heise; Matthew B Frieman; Luis L Rodriguez; Kristen A Bernard; David E Wentworth; Timothy B Stockwell; Reed S Shabman
Journal:  mSystems       Date:  2016-06-07       Impact factor: 6.496

Review 7.  Pathogen safety of plasma-derived products - Haemate P/Humate-P.

Authors:  A Gröner
Journal:  Haemophilia       Date:  2008-11       Impact factor: 4.287

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.